Can electrical stimulation of the leg alleviate bladder problems caused by stroke?
CADASIL is one of the most common genetic causes of stroke and dementia. Currently, there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
A pilot study for developing and evaluating a care pathway for cognitive problems after stroke.
Exploring the causes of ‘jargon speech’ through electrophysiology and using it to help stroke survivors that deal with it.
Although stroke survivors have reported fatigue as a problem, previous estimates of the numbers of people affected have varied greatly – from one-quarter to almost three-quarters of stroke survivors.
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.
The Stroke Association is a member of the Association of Medical Research Charities (AMRC), which is the national membership organisation of leading medical and health research charities in the UK. Published today, the AMRC's 'Making a difference: Impact report 2017' highlights how the research of its member charities makes a difference.
This project aims to develop and test a repetitive functional task practice (RFTP) therapy programme. Research physiotherapists will develop the programme in conjunction with stroke unit staff and patients.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.